Healios K.K.
4593.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.22 | 0.24 | 0.00 | -0.13 |
| FCF Yield | -1.34% | -1.69% | -2.98% | -3.63% |
| EV / EBITDA | 88.35 | -83.97 | -57.45 | -19.03 |
| Quality | ||||
| ROIC | -6.28% | -8.31% | -6.96% | -4.44% |
| Gross Margin | -494.74% | -513.64% | -155.26% | -66.67% |
| Cash Conversion Ratio | -1.33 | 0.38 | 0.30 | -2.26 |
| Growth | ||||
| Revenue 3-Year CAGR | -17.70% | -13.82% | 89.80% | 83.93% |
| Free Cash Flow Growth | 1.46% | -5.94% | -33.45% | -300.00% |
| Safety | ||||
| Net Debt / EBITDA | -6.08 | 6.79 | 7.02 | 1.28 |
| Interest Coverage | 0.00 | -0.57 | -0.36 | 0.64 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 724.82 | 407.15 | 36.19 | -577.00 |